Enzychem Lifesciences Corporation (KOSDAQ:183490)

Enzychem Lifesciences Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 18, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	88,500	113,768	154,649	139,497	457,391	869,255
Market Cap Growth	-24.39%	-26.43%	10.86%	-69.50%	-47.38%	57.11%
Enterprise Value	-16,449	3,162	16,479	-29,937	400,389	835,243
Last Close Price	1140.00	1425.00	1818.00	1655.00	9150.00	13885.04
PS Ratio	1.23	1.47	2.03	5.24	19.91	33.67
PB Ratio	0.59	0.71	0.80	0.69	6.13	11.99
P/TBV Ratio	0.61	0.73	0.82	0.70	6.73	12.33
EV/Sales Ratio	-	0.04	0.22	-	17.43	32.35
Debt / Equity Ratio	0.03	0.03	0.03	0.19	0.70	0.59
Net Debt / Equity Ratio	-0.71	-0.69	-0.68	-0.77	-0.57	-0.65
Net Debt / EBITDA Ratio	7.25	8.69	11.74	12.64	2.29	2.78
Net Debt / FCF Ratio	37.87	124.97	10.53	6.96	1.75	2.81
Asset Turnover	0.40	0.39	0.33	0.14	0.18	0.25
Inventory Turnover	5.78	5.40	5.80	2.67	2.59	2.82
Quick Ratio	14.85	11.04	10.63	4.79	1.87	9.72
Current Ratio	17.56	13.03	12.33	5.21	2.05	10.73
Return on Equity (ROE)	-14.74%	-12.40%	-4.74%	-18.16%	-37.87%	-23.90%
Return on Assets (ROA)	-6.25%	-5.21%	-4.01%	-4.81%	-10.10%	-11.44%
Return on Capital Employed (ROCE)	-11.20%	-9.60%	-7.50%	-7.10%	-26.10%	-16.80%
Earnings Yield	-27.47%	-19.43%	-6.03%	-17.99%	-6.09%	-2.01%
FCF Yield	-3.17%	-0.79%	-8.09%	-15.97%	-5.34%	-1.94%
Buyback Yield / Dilution	5.68%	3.50%	-7.75%	-56.10%	-3.93%	-3.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.